CN104107244A - Lipid regulation and pulse-beat invigoration pill - Google Patents
Lipid regulation and pulse-beat invigoration pill Download PDFInfo
- Publication number
- CN104107244A CN104107244A CN201410089767.6A CN201410089767A CN104107244A CN 104107244 A CN104107244 A CN 104107244A CN 201410089767 A CN201410089767 A CN 201410089767A CN 104107244 A CN104107244 A CN 104107244A
- Authority
- CN
- China
- Prior art keywords
- pill
- radix
- blood
- invigoration
- beat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a liquid regulation and pulse-beat invigoration pill. The invention relates to a Chinese patent medicine, and especially relates to a Chinese patent medicinal water-honeyed pill for treating high viscosity and high lipid of blood. A technical scheme is characterized in that no medicines for comprehensively regulating and treating the high viscosity and high lipid of blood exist in the current medical market, and the liquid regulation and pulse-beat invigoration pill can comprehensively regulate and treat the high viscosity and high lipid of blood. A formula of the pill comprises Capillary Wormwood Herb, cassia seed, hawthorn fruit, Rheum officinale, Salvia miltiorrhiza, Atractylodes lancea, dried orange peel, Radix Paeoniae Rubra, Cortex Moutan, Eucommia ulmoides, Achyranthes bidentata, Polygonum multiflorum, Spica Prunellae, Panax Notoginseng and licorice root. The pill is mainly used for treating the high viscosity and high lipid of middle-aged and elderly people's arteriosclerosis blood.
Description
Technical field: the present invention relates to a kind of Chinese patent medicine, particularly relate to a kind of a kind of Chinese patent medicine water-honeyed pill for the treatment of high blood viscosity hyperlipemia.
Background technology: Herba Artemisiae Scopariae: 3 grams of per kilograms of Herba Artemisiae Scopariae water decoction are to experimental atherosclerosis rabbit, and administration 2-3 Zhou Houke declines serum cholesterol and beta lipoprotein.The new medical college in " Chinese medicine voluminous dictionary " Jiangsu is compiled, Shanghai science tech publishing house, in July, 1977 first edition, the 10th printing of calendar year 2001 JIUYUE.The 1588th page of Herba Artemisiae Scopariae article of volume two, pharmacological action other.
Semen Cassiae: reduce serum cholesterol." Chinese medicine voluminous dictionary " version is the same, 949 pages of Semen Cassiae bars of the first volume, clinical report item.
Fructus Crataegi: Fructus Crataegi fluid extract has the effect of the cholesterolemia of reduction to experimental cholesterol atherosclerotic rabbit, improves the ratio of lecithin, cholesterol, reduces cholesterinosis and the effect of reducing blood pressure of organ." Chinese medicine voluminous dictionary " version is the same, and 170 pages of Fructus Crataegi bars of the first volume, under pharmacology antibacterial action item.
Summary of the invention: in the medicine that the technical problem that (1) will solve: i generally uses at present, seldom have can reduce blood viscosity high can also blood fat reducing for a kind of medicine of middle-aged and elderly people atherosclerosis comprehensively regulating.Ii adjusts fat Tongmai pills can reduce again blood viscosity in effectively reducing blood fat can comprehensively regulating for middle-aged and elderly people atherosclerosis.
(2) technical scheme: adjust fat Tongmai pills formula composition: Herba Artemisiae Scopariae, Semen Cassiae, Fructus Crataegi, Radix Et Rhizoma Rhei, Radix Salviae Miltiorrhizae, Rhizoma Atractylodis, Pericarpium Citri Reticulatae, Radix Paeoniae Rubra, Cortex Moutan, the Cortex Eucommiae, Radix Achyranthis Bidentatae, Radix Polygoni Multiflori, Spica Prunellae, Radix Notoginseng, Radix Glycyrrhizae.
(3) beneficial effect: the traditional Chinese medical science thinks that blood fat is high, blood is thick is to belong to the cause of disease basis that phlegm-turbidity and blood stasis blood obstruction of meridian is thrombotic disease, the turbid and blood stasis of expectorant often and deposit, and current medicine often curative effect is single, such as Xuezhikang, simvastatin etc. can only blood fat reducing; FUFANG DANSHEN PIAN etc. can only reduce blood viscosity.Lack at present a kind of a kind of medicine that can blood fat reducing can reduce again blood viscosity, and adjust fat Tongmai pills comprehensive 2 kinds of causes of disease to treat simultaneously, its clinical disease is improved degree, laboratory indexes reduction degree and is far superior to Xuezhikang, simvastatin, FUFANG DANSHEN PIAN and combines the effect of taking.
Detailed description of the invention: selected all formula prepared slices of Chinese crude drugs sieve is excessively cleaned and dried, smash and be coarse granule state and decoct with water to filter and abandon medicinal residues taking liquid with pulverizer, the medicinal liquid cold drying of having filtered is become to block solid content, solid content is entered to pulverizer to be smashed sieve and became yellowish-brown drug powder, this drug powder is adjusted fat Tongmai pills crude drug exactly, and this crude drug can become by manufacturing water-honeyed pill processes the water-honeyed pill of diameter 4mm or 6mm.Also can dress up capsule or be pressed into tablet.
Claims (2)
1. adjust fat Tongmai pills formula composition: Herba Artemisiae Scopariae, Semen Cassiae, Fructus Crataegi, Radix Et Rhizoma Rhei, Radix Salviae Miltiorrhizae, Rhizoma Atractylodis, Pericarpium Citri Reticulatae, Radix Paeoniae Rubra, Cortex Moutan, the Cortex Eucommiae, Radix Achyranthis Bidentatae, Radix Polygoni Multiflori, Spica Prunellae, Radix Notoginseng, Radix Glycyrrhizae.
2. selected all formula prepared slices of Chinese crude drugs sieve is excessively cleaned and dried, smash and be coarse granule state and decoct with water to filter and abandon medicinal residues taking liquid with pulverizer, the medicinal liquid cold drying of having filtered is become to block solid content, solid content is entered to pulverizer to be smashed sieve and became yellowish-brown drug powder, this drug powder is adjusted fat Tongmai pills crude drug exactly, and this crude drug can become by manufacturing water-honeyed pill processes the water-honeyed pill of diameter 4mm or 6mm.Also can dress up capsule or be pressed into tablet.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410089767.6A CN104107244A (en) | 2014-03-05 | 2014-03-05 | Lipid regulation and pulse-beat invigoration pill |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410089767.6A CN104107244A (en) | 2014-03-05 | 2014-03-05 | Lipid regulation and pulse-beat invigoration pill |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104107244A true CN104107244A (en) | 2014-10-22 |
Family
ID=51704363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410089767.6A Pending CN104107244A (en) | 2014-03-05 | 2014-03-05 | Lipid regulation and pulse-beat invigoration pill |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104107244A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104706838A (en) * | 2015-03-26 | 2015-06-17 | 王凯 | Preparation method of blood-activating, stasis-removing, lipid-lowering and fat-reducing capsule |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1334104A (en) * | 2001-02-10 | 2002-02-06 | 薛志祥 | Hypolipemic pill |
CN101664513A (en) * | 2008-09-01 | 2010-03-10 | 陈群 | Chinese herbal medicinal composition for treating hyperlipidaemia |
CN102188560A (en) * | 2010-03-08 | 2011-09-21 | 张锡林 | Traditional Chinese medicine for treating hyperlipidemia |
CN102552468A (en) * | 2011-12-28 | 2012-07-11 | 蚌埠丰原涂山制药有限公司 | Traditional Chinese medicine composition for treating hyperlipidemia |
-
2014
- 2014-03-05 CN CN201410089767.6A patent/CN104107244A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1334104A (en) * | 2001-02-10 | 2002-02-06 | 薛志祥 | Hypolipemic pill |
CN101664513A (en) * | 2008-09-01 | 2010-03-10 | 陈群 | Chinese herbal medicinal composition for treating hyperlipidaemia |
CN102188560A (en) * | 2010-03-08 | 2011-09-21 | 张锡林 | Traditional Chinese medicine for treating hyperlipidemia |
CN102552468A (en) * | 2011-12-28 | 2012-07-11 | 蚌埠丰原涂山制药有限公司 | Traditional Chinese medicine composition for treating hyperlipidemia |
Non-Patent Citations (3)
Title |
---|
任爱农: "《药品HPLC快速检测.中成药》", 31 July 2009, 化学工业出版社 * |
张敏芳等,: "祛脂汤配藻酸双脂钠治疗脂肪肝35例", 《陕西中医》 * |
石珊珊等,: "丹桔胶囊的质量标准研究", 《中国医药学报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104706838A (en) * | 2015-03-26 | 2015-06-17 | 王凯 | Preparation method of blood-activating, stasis-removing, lipid-lowering and fat-reducing capsule |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hou et al. | Origin and concept of medicine food homology and its application in modern functional foods | |
CN103784820B (en) | For treating Chinese medicine formula and the Chinese medicinal capsule of cardiovascular stasis coronary heart disease | |
CN1785284B (en) | Medicinal composition containing flowery knotwood root | |
CN103230548B (en) | Traditional Chinese medicine composition for treating pulmonary heart disease | |
CN101274042A (en) | Medicament composition for curing hyperlipemia and method of preparing the same | |
CN104587441A (en) | Cardiovascular disease regulating traditional Chinese medicine composition and preparation method thereof | |
CN103877263A (en) | Anti-fatigue health-prservation preparation prepared from composite traditional Chinese medicines including red ginseng, maca and green tea extract (theanine) | |
CN102614387A (en) | Traditional Chinese medicine for prevention and treatment of stroke and preparation method thereof | |
CN101953918B (en) | Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases | |
CN103784888A (en) | Traditional Chinese medicine for treating coronary atherosclerotic heart disease caused by qi deficiency and blood stasis | |
CN1103223C (en) | Chinese medicine for treating cholecystitis | |
CN102397351A (en) | Traditional Chinese medicinal composition for treating insomnia | |
CN1167452C (en) | Medicine for treating AIDS | |
CN103479691A (en) | Lipid-decreasing liver protection traditional Chinese medicine composition | |
CN103768297A (en) | Traditional Chinese medicine for treating hyperlipoidemia | |
CN102552527B (en) | Traditional Chinese medicine composition used for treating diabetic complications and reducing blood sugar and preparation method thereof | |
CN102100873B (en) | Chinese patent medicine for treating heart cerebrovascular diseases and preparation method thereof | |
CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
CN101480472B (en) | Medicament for reducing blood pressure and regulating blood fat and production method | |
CN104107244A (en) | Lipid regulation and pulse-beat invigoration pill | |
CN101461900B (en) | Pure medicinal formulation for treating arteriosclerosis | |
CN103751547A (en) | Traditional Chinese medicinal composition for reducing blood lipid and preparation method thereof | |
CN101167921A (en) | Medicinal composition for treating stomachache and preparation process thereof | |
CN103735899A (en) | Hypertension injection nursing drug and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141022 |
|
RJ01 | Rejection of invention patent application after publication |